Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Wendy Armstrong

Concepts (371)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
68
2026
3154
5.710
 Why?
Epidemics
7
2026
98
2.240
 Why?
Communicable Diseases
8
2023
163
1.840
 Why?
Anti-Retroviral Agents
5
2019
250
1.640
 Why?
Anti-HIV Agents
14
2026
888
1.570
 Why?
Viral Load
14
2026
526
1.150
 Why?
Infectious Disease Medicine
2
2017
12
1.050
 Why?
Continuity of Patient Care
5
2022
292
0.970
 Why?
AIDS-Related Opportunistic Infections
5
2019
130
0.880
 Why?
HIV
13
2023
250
0.880
 Why?
Internal Medicine
3
2016
280
0.870
 Why?
Social Stigma
2
2024
172
0.830
 Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
20
0.750
 Why?
Internship and Residency
6
2021
1257
0.680
 Why?
Pre-Exposure Prophylaxis
3
2024
246
0.670
 Why?
Drug Monitoring
2
2016
395
0.650
 Why?
Antiretroviral Therapy, Highly Active
6
2019
278
0.630
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
19
0.620
 Why?
Adenine
2
2020
339
0.610
 Why?
Diagnostic Tests, Routine
2
2021
108
0.600
 Why?
Acquired Immunodeficiency Syndrome
7
2022
235
0.600
 Why?
Humans
97
2026
144957
0.590
 Why?
Consumer Advocacy
1
2018
12
0.560
 Why?
United States
27
2026
15988
0.550
 Why?
Lost to Follow-Up
2
2017
20
0.550
 Why?
Career Choice
3
2018
237
0.550
 Why?
HIV-1
8
2026
896
0.530
 Why?
Delivery of Health Care
4
2021
947
0.510
 Why?
Health Policy
3
2023
401
0.510
 Why?
Health Services Accessibility
4
2024
1099
0.500
 Why?
CD4 Lymphocyte Count
6
2020
277
0.480
 Why?
Georgia
10
2024
83
0.470
 Why?
Substance-Related Disorders
6
2021
1094
0.470
 Why?
Medication Adherence
2
2017
539
0.460
 Why?
Rilpivirine
2
2026
10
0.460
 Why?
Antimicrobial Stewardship
3
2023
130
0.440
 Why?
Disease Management
1
2019
647
0.440
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
11
0.430
 Why?
Urban Population
1
2017
491
0.410
 Why?
Biomedical Research
2
2018
710
0.410
 Why?
Bone Diseases
1
2014
61
0.410
 Why?
Financing, Government
1
2014
53
0.400
 Why?
Metabolic Diseases
1
2014
114
0.390
 Why?
Drug Resistance, Viral
2
2005
123
0.380
 Why?
Patient Acceptance of Health Care
2
2017
886
0.380
 Why?
Rural Population
1
2017
650
0.360
 Why?
Ventriculostomy
1
2012
24
0.360
 Why?
Medication Errors
1
2012
83
0.350
 Why?
Chronic Pain
3
2021
292
0.350
 Why?
Central Nervous System Diseases
1
2012
74
0.340
 Why?
Mycoses
1
2012
88
0.340
 Why?
Ambulatory Care
2
2021
603
0.330
 Why?
Prostheses and Implants
1
2012
141
0.330
 Why?
Disease Transmission, Infectious
1
2011
69
0.320
 Why?
Gram-Positive Bacterial Infections
2
2008
70
0.320
 Why?
Critical Care
1
2016
697
0.310
 Why?
Cellulitis
2
2011
53
0.310
 Why?
Microbiology
3
2014
24
0.310
 Why?
Bacterial Infections
1
2012
246
0.310
 Why?
Physicians
5
2019
940
0.300
 Why?
Analgesics, Opioid
5
2021
1143
0.300
 Why?
Dermatitis
1
2008
19
0.290
 Why?
Medical Informatics
1
2009
97
0.290
 Why?
Male
41
2026
72406
0.290
 Why?
Female
42
2026
78376
0.280
 Why?
Patient-Centered Care
1
2014
544
0.280
 Why?
Global Health
2
2018
401
0.280
 Why?
Gram-Negative Bacterial Infections
1
2008
51
0.280
 Why?
Adult
33
2026
40506
0.280
 Why?
Education, Medical, Graduate
5
2023
557
0.260
 Why?
Middle Aged
32
2026
35928
0.260
 Why?
Africa, Eastern
2
2017
12
0.260
 Why?
Delayed Diagnosis
2
2026
95
0.260
 Why?
AIDS Vaccines
2
2005
52
0.260
 Why?
Information Dissemination
1
2009
223
0.260
 Why?
Periodicals as Topic
1
2009
203
0.250
 Why?
Viremia
2
2026
158
0.240
 Why?
Pneumonia, Pneumocystis
4
2015
34
0.240
 Why?
Pyridones
2
2026
199
0.240
 Why?
Developing Countries
3
2017
318
0.240
 Why?
Mycobacterium chelonae
1
2005
8
0.240
 Why?
Internet
2
2014
700
0.230
 Why?
Curriculum
5
2023
1060
0.230
 Why?
Databases, Factual
2
2019
1486
0.220
 Why?
Exosomes
2
2016
104
0.210
 Why?
Skin
1
2008
758
0.200
 Why?
Meningoencephalitis
1
2003
24
0.200
 Why?
Fellowships and Scholarships
4
2023
357
0.200
 Why?
Cost-Benefit Analysis
3
2021
636
0.190
 Why?
West Nile virus
1
2003
41
0.190
 Why?
Practice Guidelines as Topic
3
2019
1563
0.190
 Why?
Interviews as Topic
2
2017
901
0.180
 Why?
Bacteria
1
2008
889
0.180
 Why?
Anti-Infective Agents
3
2015
242
0.180
 Why?
Pain Management
3
2021
405
0.180
 Why?
Simulation Training
1
2023
134
0.170
 Why?
Colony-Stimulating Factors
1
2001
37
0.170
 Why?
Coronary Artery Bypass
1
2003
269
0.170
 Why?
Pandemics
4
2026
1695
0.170
 Why?
Erythrocyte Transfusion
1
2003
231
0.170
 Why?
Contact Tracing
1
2020
26
0.170
 Why?
Obesity
1
2014
3082
0.160
 Why?
Mycobacterium Infections, Nontuberculous
1
2005
366
0.160
 Why?
Prescription Drug Misuse
1
2021
51
0.160
 Why?
Mass Screening
2
2020
1348
0.160
 Why?
Cities
4
2022
143
0.160
 Why?
Models, Theoretical
2
2021
582
0.160
 Why?
Sexual and Gender Minorities
1
2024
251
0.160
 Why?
Erythropoietin
1
2001
100
0.160
 Why?
Registries
2
2019
2385
0.160
 Why?
Antibodies, Monoclonal, Humanized
1
2026
988
0.150
 Why?
Policy
1
2021
147
0.150
 Why?
Life Expectancy
1
2020
72
0.150
 Why?
Interleukin-2
1
2001
437
0.150
 Why?
Fever of Unknown Origin
1
1999
13
0.150
 Why?
Alanine
1
2020
171
0.150
 Why?
Heart Diseases
1
2022
350
0.150
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
38
0.140
 Why?
Cross-Sectional Studies
5
2021
5872
0.140
 Why?
Health Equity
1
2021
129
0.140
 Why?
Cohort Studies
7
2019
5965
0.140
 Why?
Mentors
2
2018
219
0.140
 Why?
Comorbidity
2
2020
1660
0.140
 Why?
Prevalence
5
2024
2836
0.140
 Why?
Microbial Sensitivity Tests
3
2016
371
0.140
 Why?
Sexually Transmitted Diseases
1
2020
166
0.130
 Why?
Tenofovir
1
2020
295
0.130
 Why?
Physician Assistants
1
2019
102
0.130
 Why?
Capital Financing
1
2017
7
0.130
 Why?
Patient Identification Systems
1
2017
16
0.130
 Why?
Sustained Virologic Response
1
2017
46
0.130
 Why?
Africa
1
2017
116
0.130
 Why?
Nurse Practitioners
1
2019
140
0.130
 Why?
Hospitalization
4
2020
2434
0.130
 Why?
Risk Factors
7
2020
10792
0.130
 Why?
Anti-Bacterial Agents
4
2011
1915
0.120
 Why?
Financing, Personal
1
2016
27
0.120
 Why?
Viral Tropism
1
2016
36
0.120
 Why?
Research Personnel
1
2018
186
0.120
 Why?
Case Management
1
2016
68
0.120
 Why?
Motivation
2
2017
610
0.110
 Why?
Hospitals
2
2021
732
0.110
 Why?
Diketopiperazines
2
2026
22
0.110
 Why?
Pneumonia, Viral
1
2020
384
0.110
 Why?
Opioid-Related Disorders
2
2021
601
0.110
 Why?
Coronavirus Infections
1
2020
378
0.110
 Why?
Drug Utilization Review
1
2015
61
0.110
 Why?
Organizational Policy
1
2015
76
0.110
 Why?
HIV Protease Inhibitors
1
2015
69
0.110
 Why?
Online Systems
1
2014
21
0.110
 Why?
Esophageal Diseases
1
2015
30
0.110
 Why?
Candidiasis
1
2015
64
0.110
 Why?
Time-to-Treatment
1
2017
245
0.110
 Why?
Cytosol
1
2015
227
0.110
 Why?
Patient Navigation
1
2016
104
0.110
 Why?
Pregnancy Complications, Infectious
1
2019
428
0.100
 Why?
Retrospective Studies
8
2026
17101
0.100
 Why?
Alcoholism
1
2021
817
0.100
 Why?
Drug Interactions
1
2015
401
0.100
 Why?
Organophosphates
1
2015
187
0.100
 Why?
Healthcare Disparities
1
2020
728
0.100
 Why?
Ambulatory Care Facilities
1
2016
266
0.100
 Why?
Patient Readmission
1
2019
759
0.100
 Why?
DNA, Viral
2
2012
358
0.100
 Why?
Health Plan Implementation
1
2014
136
0.090
 Why?
Dihydropteroate Synthase
2
2004
3
0.090
 Why?
Medication Reconciliation
1
2012
31
0.090
 Why?
Leukocytes, Mononuclear
1
2015
573
0.090
 Why?
Incidence
2
2021
2883
0.090
 Why?
Oligopeptides
1
2014
269
0.090
 Why?
Telemedicine
1
2021
948
0.090
 Why?
Pilot Projects
2
2017
1890
0.090
 Why?
HIV Antibodies
1
2012
60
0.090
 Why?
Myocardial Infarction
2
2019
1209
0.090
 Why?
Longitudinal Studies
2
2019
2947
0.090
 Why?
Socioeconomic Factors
2
2020
1327
0.090
 Why?
Aged
8
2022
25947
0.090
 Why?
Mycobacterium haemophilum
1
2011
1
0.090
 Why?
Primary Health Care
2
2019
1734
0.090
 Why?
Parasitic Diseases
1
2011
8
0.080
 Why?
Research
1
2014
431
0.080
 Why?
Cytomegalovirus
1
2012
168
0.080
 Why?
Pneumocystis
2
2001
8
0.080
 Why?
Catheter-Related Infections
1
2012
94
0.080
 Why?
Mycobacterium Infections
1
2011
61
0.080
 Why?
Simian Immunodeficiency Virus
1
2011
92
0.080
 Why?
Electronic Health Records
1
2019
1177
0.080
 Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
92
0.080
 Why?
Health Care Costs
1
2014
427
0.080
 Why?
Geography
1
2011
203
0.080
 Why?
Cytokines
2
2016
2065
0.080
 Why?
Education, Medical, Undergraduate
1
2013
207
0.080
 Why?
Surveys and Questionnaires
5
2023
6053
0.080
 Why?
Cytomegalovirus Infections
1
2012
206
0.080
 Why?
Sulfonamides
1
2014
581
0.080
 Why?
Rectum
1
2011
180
0.080
 Why?
Pyridines
1
2014
605
0.080
 Why?
Antibodies, Neutralizing
1
2012
341
0.070
 Why?
Adolescent
5
2021
22453
0.070
 Why?
Desiccation
1
2009
24
0.070
 Why?
Deep Brain Stimulation
1
2012
213
0.070
 Why?
Education, Medical, Continuing
1
2009
132
0.070
 Why?
Colon
1
2011
305
0.070
 Why?
Drug Therapy, Combination
3
2014
1048
0.070
 Why?
Emigrants and Immigrants
1
2011
158
0.070
 Why?
Syphilis, Cutaneous
1
2007
3
0.070
 Why?
Immunoglobulin G
1
2012
893
0.070
 Why?
Dendritic Cells
1
2011
499
0.070
 Why?
Hepacivirus
1
2009
243
0.060
 Why?
Specimen Handling
1
2009
186
0.060
 Why?
Plasma
1
2009
225
0.060
 Why?
Risk Assessment
3
2019
3676
0.060
 Why?
B-Lymphocytes
1
2012
877
0.060
 Why?
Treatment Outcome
6
2024
11695
0.060
 Why?
Young Adult
3
2021
14126
0.060
 Why?
Hepatitis C
1
2009
254
0.060
 Why?
Acetamides
1
2026
38
0.060
 Why?
Indazoles
1
2026
80
0.060
 Why?
HIV-2
1
2005
18
0.060
 Why?
Diagnosis, Differential
2
2007
1495
0.050
 Why?
Dapsone
2
2004
8
0.050
 Why?
CD4-Positive T-Lymphocytes
1
2011
1129
0.050
 Why?
Sex Factors
1
2011
2114
0.050
 Why?
Patient Education as Topic
1
2009
780
0.050
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
42
0.050
 Why?
Pneumocystis carinii
1
2004
12
0.050
 Why?
Chronic Disease
2
2012
1813
0.050
 Why?
Mediastinitis
1
2003
3
0.050
 Why?
Virulence
1
2005
280
0.050
 Why?
Vancomycin Resistance
1
2003
16
0.050
 Why?
Enterococcus faecium
1
2003
22
0.050
 Why?
Delayed-Action Preparations
1
2024
183
0.050
 Why?
Wound Healing
1
2005
351
0.050
 Why?
Fatal Outcome
1
2003
307
0.050
 Why?
Liver Failure
1
2002
83
0.040
 Why?
Biopsy
1
2005
1077
0.040
 Why?
Transplantation, Homologous
1
2002
415
0.040
 Why?
Cryptococcosis
1
2001
31
0.040
 Why?
Dental Care
1
2021
26
0.040
 Why?
Intracranial Hypertension
1
2001
41
0.040
 Why?
Naphthoquinones
1
2001
19
0.040
 Why?
Coronary Disease
2
2003
386
0.040
 Why?
Blood
2
2012
109
0.040
 Why?
Cytochrome b Group
1
2001
22
0.040
 Why?
Quality-Adjusted Life Years
1
2021
121
0.040
 Why?
Adipose Tissue
1
2005
653
0.040
 Why?
Mutation
2
2004
4099
0.040
 Why?
Time Factors
3
2019
7183
0.040
 Why?
Patient Outcome Assessment
1
2021
134
0.040
 Why?
Meningitis
1
2001
80
0.040
 Why?
Renal Insufficiency
1
2002
169
0.040
 Why?
Neutropenia
1
2001
155
0.040
 Why?
Antifungal Agents
1
2001
149
0.040
 Why?
Trust
1
2021
153
0.040
 Why?
Prospective Studies
1
2012
7997
0.040
 Why?
Personal Satisfaction
1
2021
222
0.040
 Why?
Anemia
1
2001
188
0.040
 Why?
JC Virus
1
2019
23
0.040
 Why?
Spinal Diseases
1
1999
50
0.040
 Why?
Polyomavirus Infections
1
2019
29
0.040
 Why?
Boston
1
2019
92
0.040
 Why?
Asymptomatic Infections
1
2019
37
0.040
 Why?
Antiviral Agents
1
2005
768
0.040
 Why?
Esophageal Stenosis
1
1999
57
0.040
 Why?
Abscess
1
1999
75
0.040
 Why?
Polymerase Chain Reaction
3
2011
1054
0.040
 Why?
Antibodies, Monoclonal
1
2026
1524
0.040
 Why?
Insurance, Health
1
2021
303
0.040
 Why?
Training Support
1
2018
36
0.030
 Why?
Benchmarking
1
2019
188
0.030
 Why?
Health Status Disparities
1
2021
321
0.030
 Why?
Preceptorship
1
2018
67
0.030
 Why?
Recombinant Proteins
1
2001
1371
0.030
 Why?
Substance Abuse Detection
1
2019
106
0.030
 Why?
Heart-Assist Devices
1
2003
567
0.030
 Why?
Dyslipidemias
1
2019
182
0.030
 Why?
Multicenter Studies as Topic
1
2019
405
0.030
 Why?
Patient Satisfaction
1
2021
705
0.030
 Why?
Hospitals, Public
1
2017
30
0.030
 Why?
Drug Administration Schedule
1
2019
783
0.030
 Why?
Prenatal Care
1
2019
307
0.030
 Why?
Odds Ratio
1
2019
1077
0.030
 Why?
Medicare
1
2022
887
0.030
 Why?
Postpartum Period
1
2019
365
0.030
 Why?
Ultracentrifugation
1
2016
51
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
Needs Assessment
1
2018
404
0.030
 Why?
Multivariate Analysis
1
2019
1540
0.030
 Why?
Virion
1
2016
111
0.030
 Why?
Stents
1
1999
556
0.030
 Why?
Motivational Interviewing
1
2016
121
0.030
 Why?
Guideline Adherence
1
2019
589
0.030
 Why?
Neopterin
1
2014
13
0.030
 Why?
Darunavir
1
2014
20
0.030
 Why?
Atazanavir Sulfate
1
2014
42
0.030
 Why?
Societies, Medical
1
2018
887
0.030
 Why?
Ritonavir
1
2014
75
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2016
851
0.020
 Why?
Antigens, CD
1
2016
555
0.020
 Why?
Randomized Controlled Trials as Topic
1
2019
1721
0.020
 Why?
Biomarkers
2
2016
4275
0.020
 Why?
Qualitative Research
1
2020
1671
0.020
 Why?
Blood Proteins
1
2014
249
0.020
 Why?
Transplantation
1
2012
33
0.020
 Why?
Smoking
1
2019
1472
0.020
 Why?
Inpatients
1
2016
546
0.020
 Why?
Rifabutin
1
2011
7
0.020
 Why?
Clarithromycin
1
2011
25
0.020
 Why?
Ofloxacin
1
2011
17
0.020
 Why?
Receptors, Immunologic
1
2012
206
0.020
 Why?
Integrins
1
2011
90
0.020
 Why?
Macaca mulatta
1
2011
191
0.020
 Why?
Hypertension
1
2019
1264
0.020
 Why?
Quality of Life
1
2023
3192
0.020
 Why?
RNA, Viral
1
2014
688
0.020
 Why?
Data Interpretation, Statistical
1
2012
372
0.020
 Why?
Programmed Cell Death 1 Receptor
1
2012
264
0.020
 Why?
Practice Patterns, Physicians'
1
2019
1358
0.020
 Why?
Immunocompromised Host
1
2011
201
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
758
0.020
 Why?
Blotting, Western
1
2011
1187
0.020
 Why?
Health Promotion
1
2015
774
0.020
 Why?
Cells, Cultured
1
2016
4155
0.020
 Why?
False Negative Reactions
1
2007
61
0.020
 Why?
Feces
1
2011
513
0.020
 Why?
Protein Binding
1
2014
2276
0.020
 Why?
Lymphocyte Activation
1
2011
1126
0.020
 Why?
Flow Cytometry
1
2011
1173
0.020
 Why?
Neoplasms
1
2002
2884
0.020
 Why?
Cardiovascular Diseases
1
2019
2171
0.020
 Why?
Pregnancy
1
2019
7191
0.010
 Why?
Gene Expression Profiling
1
2011
1786
0.010
 Why?
Genotype
1
2009
1835
0.010
 Why?
T-Lymphocytes
1
2012
1982
0.010
 Why?
Chemoprevention
1
2004
90
0.010
 Why?
China
1
2004
269
0.010
 Why?
Infant
1
2016
10039
0.010
 Why?
Atovaquone
1
2001
4
0.010
 Why?
Survival
1
2001
38
0.010
 Why?
Child, Preschool
1
2016
11799
0.010
 Why?
Ubiquinone
1
2001
35
0.010
 Why?
Reproducibility of Results
1
2009
3415
0.010
 Why?
Gene Amplification
1
2001
121
0.010
 Why?
Cardiomyopathy, Dilated
1
2003
359
0.010
 Why?
Sulfones
1
2000
127
0.010
 Why?
Epidural Space
1
1999
17
0.010
 Why?
Postoperative Complications
2
2003
2920
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
222
0.010
 Why?
Animals
2
2011
38109
0.010
 Why?
Recurrence
1
2001
1135
0.010
 Why?
Polymorphism, Genetic
1
2001
612
0.010
 Why?
Radiation Injuries
1
1999
151
0.010
 Why?
Esophagus
1
1999
261
0.010
 Why?
Heart Transplantation
1
2003
736
0.010
 Why?
Molecular Sequence Data
1
2001
2931
0.010
 Why?
Child
1
2016
22657
0.010
 Why?
Esophageal Neoplasms
1
1999
349
0.010
 Why?
Carcinoma, Squamous Cell
1
1999
642
0.010
 Why?
Follow-Up Studies
1
2003
5417
0.010
 Why?
Case-Control Studies
1
2001
3608
0.010
 Why?
Angina Pectoris
1
1971
75
0.010
 Why?
Coronary Vessels
1
1971
251
0.000
 Why?
Tomography, X-Ray Computed
1
1999
2738
0.000
 Why?
Aorta
1
1971
430
0.000
 Why?
Magnetic Resonance Imaging
1
1999
3869
0.000
 Why?
Angiocardiography
1
1971
1
0.000
 Why?
Methods
1
1971
69
0.000
 Why?
Extracorporeal Circulation
1
1971
15
0.000
 Why?
Saphenous Vein
1
1971
37
0.000
 Why?
Transplantation, Autologous
1
1971
292
0.000
 Why?
Emergencies
1
1971
176
0.000
 Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (371) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)